Mainstream Media Blackout on nasal spray that is 99% effective against Covid-19 in its Phase 3 clinical trial.

https://www.thegatewaypundit.com/2022/02/media-blackout-nasal-spray-99-effective-covid-19-phase-3-clinical-trial-now-approved-india-israel-bahrain-indonesia-thailand/ 

The Canadian pharmaceutical company SaNOtize Research & Development Corp., (SaNOtize), and Glenmark Pharmaceuticals Limted (Glenmark), announced earlier this month the successful outcomes of a nasal spray in its Phase 3 clinical trials and now approved by India's drug regulator as a treatment for adult patients with Covid-19 who have a risk of progression of the disease.

The SaNOTize Nitric Oxide Nasal Spray (NONS) reduced the SARS-CoV-2 log viral load in Covid-19 patients by more than 94% within 24 hours of treatment, and by more than 99% in 48 hours as compared to saline control.

NONS has a marketing authorization as Class 1 Medical Device in the EU, and is also approved and being sold in Israel, Thailand, Indonesia and Bahrain, under the name enovid or VirX.